U-CyTech Biosciences

U-CyTech biosciences is a biotech company founded in 1999 in cooperation with Utrecht University and is located in Utrecht, The Netherlands (Europe). This business with an open-door policy and many loyal customers is engaged in fundamental and applied research in the field of cytokine biology. We are specialized in ELISA and both the T and B cell ELISPOT assays which are designed for the ex vivo detection of individual protein secreting cells. In addition, we develop ‘in house’ a wide range of highly specific monoclonal and polyclonal antibodies directed to a wide range of proteins forming the basis of our highly sensitive assays (ELISA, ELISPOT, FluoroSpot). We offer laboratory contract services in assay development to our customer's individual needs.

https://www.ucytech.com

2-10 employees

Growth Trajectory

U-CyTech can grow by expanding its distributor network, increasing bulk sales, and further developing FluoroSpot technology for broader applications and multiplexing capabilities. They also have opportunities in customized assay development to meet specific research needs, particularly in emerging therapies like immune checkpoint inhibitors and cell therapies, as well as offering services for custom assay development or sample analysis.

Technical Challenges

Ensuring product quality and consistency in immunoassay kits.

Compliance with privacy laws and regulations related to data collection and third-party data sharing.

Maintaining the website's accuracy, completeness, and timeliness of information.

Detection of autoreactive T and B cell responses at low frequencies.

Developing assays for emerging therapies and infectious diseases.

Tech Stack

ELISAELISPOTFluoroSpot

Team Size

Key Risks

Competition in the immunoassay market necessitates maintaining competitive pricing and product quality.

Compliance with international laws and regulations, especially concerning data privacy (GDPR), is crucial.

Maintaining website security and preventing data breaches is an ongoing technical challenge.

Reliance on third-party services like FedEx and PayByLink introduces potential risks related to service disruptions or security vulnerabilities.

The need for reliable immune response measurements in infectious diseases requires continuous innovation to address market demands.

Opportunities

Expand the distributor network to increase global market presence and sales.

Further develop FluoroSpot technology for simultaneous detection of multiple cytokines, addressing a market gap.

Offer customized assay development services tailored to specific research applications, catering to niche markets.

Collaborate with research institutions and pharmaceutical companies to develop new assays and applications.

Increase bulk sales by offering reduced prices and flexible shipping schedules.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes